COMMUNIQUÉS West-GlobeNewswire
-
Trethera Congratulates Board Director Dr. Timothy R. Donahue on Appointment to Senior Leadership Roles at Weill Cornell Medicine and NewYork-Presbyterian
09/09/2026 -
Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome
09/09/2026 -
Dark Horse Consulting Group Marks the Opening of Its Shanghai Office with Ribbon Cutting Ceremony
09/09/2026 -
Momenta Oral & Maxillofacial Surgery Accredited by AAAHC, Recognized as a Center of Excellence
09/09/2026 -
Acentra Health Named a Pioneer in URAC’s Leaders in Performance Measurement Program for Case Management
09/09/2026 -
Becoming Independent and Santa Rosa Junior College Partner to Bring “BI Olympics” to Santa Rosa
09/09/2026 -
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data
09/09/2026 -
Zelluna ASA – Extraordinary General Meeting held on September 9, 2026
09/09/2026 -
Medicana Uses Robot-Assisted Technology to Perform Heart Surgery Through Small Ports
09/09/2026 -
BayCare Generates $13 Billion in Economic Impact Annually for Florida
09/09/2026 -
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
09/09/2026 -
Wellcome Leap Appoints John Young and Thomas Glanzmann to Board of Directors
09/09/2026 -
Quetzal Therapeutics Appoints Harindra R. Abeysinghe, Ph.D., as Chief Regulatory and Quality Officer
09/09/2026 -
Fast Company Names Visory Health to Its 2026 Best Workplaces for Innovators List
09/09/2026 -
OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le pegrizeprument (VEL-101) dans la prévention du rejet d’organe chez les patients transplantés rénaux
09/09/2026 -
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients
09/09/2026 -
UF Health Collaborates with R1 on AI-Powered Revenue Cycle Transformation with Phare OS
09/09/2026 -
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities
09/09/2026 -
Jushi Holdings Inc. Announces Open-Market Share Purchases by Chief Executive Officer, Chairman and Founder Jim Cacioppo
09/09/2026
Pages